<DOC>
	<DOCNO>NCT02728245</DOCNO>
	<brief_summary>Randomized phase 2 trial compare preoperative dienogest therapy follow surgery vs. upfront surgery save ovarian reserve young woman ovarian endometrioma</brief_summary>
	<brief_title>Trial Comparing Preoperative Dienogest Therapy Followed Surgery vs. Upfront Surgery Save Ovarian Reserve Young Women With Ovarian Endometrioma</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Unilateral ovarian endometrioma ≥ 5cm bilateral ovarian endometriomas size diagnose ultrasonography . In Patients previous unilateral salpingooophorectomy ( USO ) Unilateral ovarian endometrioma size eligible 20 ≤ Age ≤ 45 premenopause Plan undergo conservative surgery endometriomas Pregnant woman woman suspect pregnant Women current venous thromboembolism history disease Women current arterial disease cardiovascular disease ( e.g . myocardial infarction , cerebrovascular disease , ischemic heart disease ) history disease Women current diabetes vascular lesion history disease Women current severe liver diseases history severe liver disease abnormal liver function Women current liver tumor history liver tumor Women current history sexhormone dependent malignant tumor woman suspect sexhormone dependent malignant tumor Women vaginal bleed unknown cause Women history allergic reaction element DNG Women galactose intolerance , Lapp lactase deficiency , glucosegalactose malabsorption Women whose noncompliance expect Lactation ( treatment DNG recommend lactate woman due possible excretion breast milk ) Any medication could result excessive accumulation , impaired metabolism , alter excretion study drug might interfere conduct study interpretation result</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>